CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 8-K Event Regulation FD disclosure
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $18.46 ($55,380)
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $22.39 ($67,170)
- 4 Open-market sale President and CEO sold 13,052 shares at $21.86 ($285,343)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $26.05 ($78,150)
- 8-K Event Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 4,497 shares at $25.06 ($112,689)
- 4 Open-market sale President and CEO sold 2,028 shares at $25.09 ($50,880)
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $22.56 ($67,680)
- 4 Open-market sale President and CEO sold 13,052 shares at $23.42 ($305,708)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 26 of 41 · 801 filings